FinVector Company
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.
Technology:
Others
Industry:
Gene Therapy
Headquarters:
Kuopio, Eastern Finland, Finland
Estimated Revenue:
$10M to $50M
Register and Claim Ownership